XOMA
- XOMA Corporation
()
Overview
Company Summary
XOMA Corporation is a biotechnology company that focuses on the discovery, development, and commercialization of therapeutic drugs. The company specializes in developing antibody-based therapeutics to treat various diseases and medical conditions.
XOMA primarily operates in two areas: proprietary research and development (R&D) and licensing collaborations. In its proprietary R&D programs, XOMA leverages its expertise in antibody discovery and optimization to develop novel therapeutic candidates. These candidates are aimed at addressing unmet medical needs across a range of indications, including oncology, immunology, and metabolic disorders.
Additionally, XOMA actively pursues licensing collaborations with pharmaceutical and biotechnology companies. Through these partnerships, XOMA provides its expertise and technology platforms for antibody discovery and optimization to assist in the development of potential drug candidates. These collaborations are usually structured as revenue-sharing agreements or involve upfront payments and milestone payments.
In summary, XOMA Corporation is dedicated to discovering and developing innovative antibody-based therapeutics through both its proprietary R&D programs and collaborative partnerships. The company aims to provide effective treatment options for patients facing various medical conditions, thereby contributing to the advancement of healthcare.